We process human placental tissue utilizing our proprietary PURION® process methodology, among other processes, to produce safe and effective allografts by employing aseptic processing techniques in addition to terminal sterilization.
Since our founding, research and development has been the cornerstone of our organization. As a result, we have grown to be the leader in placental based products with over 40 scientific and clinical publications contained in our Compendium, six completed and published Randomized Controlled Trials (RCTs), and 30 ongoing clinical studies. MiMedx has over 45 placental tissue issued and allowed patents on our products and technologies, with over 90 pending applications. We have continued to demonstrate this leadership by publishing a Primer to educate the medical community on the regenerative aspects of amniotic membrane allografts.
MiMedx has supplied over 1 million placental tissue-based allografts to date for application in the Wound Care, Burn, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare.
Tech stackView tech stack
Learn about the technology and tools that MiMedx uses.
MiMedx's tech stack
Tableau, Microsoft Excel, Microsoft Office 365, Azure Active Directory, and Microsoft SQL Server are some of the popular tools that MiMedx uses. Learn more about the Analytics, Back Office, Collaboration, and Data Stores in MiMedx's Tech Stack.
Assets and Media
Languages & Frameworks
We'll keep you updated when the best new remote jobs pop up.